表紙
市場調查報告書

全球臨床診斷的自動化市場

Clinical Diagnostics Automation

出版商 Global Industry Analysts, Inc. 商品編碼 243081
出版日期 內容資訊 英文 148 Pages
商品交期: 最快1-2個工作天內
價格
全球臨床診斷的自動化市場 Clinical Diagnostics Automation
出版日期: 2020年09月01日內容資訊: 英文 148 Pages
簡介

本報告提供全球臨床診斷的自動化市場相關調查,市場現狀與今後的成長預測,各地區趨勢,及加入此市場的主要企業的簡介等彙整資料。

第1章 簡介,調查方法,產品定義

第2章 產業概要

  • 自動化臨床診斷的創新
  • 新興市場大的成長的機會
  • 終端用戶及技術主導的方面使需求擴大
  • 導入自動化的實驗室的促進要素
  • 影響嚴峻的勞動市場
  • 人口統計,社會變化促進需求

第3章 市場趨勢,促進要素,課題

  • 對生化科技的投資擴大
  • 微孔盤設備
  • 模組化自動化
  • 患者治療管理上重要角色
  • 免疫組織化學的自動化對處理能力擴大 等

第4章 臨床診斷的自動化:概要

  • 實驗室自動化
  • 實驗室自動化的優點
  • 臨床診斷的自動化的引進
  • 臨床診斷的自動化的發展
  • 實驗室自動化系統的結構要素
  • 一般診斷測試所結構
  • 實驗室管理與資訊系統
  • 樣品保管
  • 樣品製做
  • 運輸
  • 分析
  • 模組化自動化:新的替代策略

第5章 競爭環境

  • 全球主要企業
    • Abaxis, Inc.
    • Abbott Diagnostics, Inc.
    • Beckman Coulter, Inc
    • Becton, Dickinson and Company
    • bioMerieux SA
    • Bio-Rad Laboratories, Inc.
    • Diagnostica Stago S.A.S.
    • Eppendorf AG
    • F. Hoffmann-La Roche Ltd.
    • HORIBA ABX S.A.S.
    • Hudson Robotics, Inc.
    • Ortho Clinical Diagnostics, Inc.
    • PerkinElmer Inc.
    • QIAGEN NV
    • Siemens Healthineers
    • Sysmex America, Inc.
    • Tecan Group Ltd.
    • The ELITechGroup SAS
    • Thermo Fisher Scientific, Inc
  • 產品引進/發展
  • 近幾年的產業活動

第6章 全球市場預測

第7章 各地區市場趨勢

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 南美
  • 其他各國

第8章 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-6034

Global Clinical Diagnostics Automation Market to Reach $7.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Clinical Diagnostics Automation estimated at US$4.1 Billion in the year 2020, is projected to reach a revised size of US$7.2 Billion by 2027, growing at a CAGR of 8.2% over the period 2020-2027.

The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 12.4% CAGR

The Clinical Diagnostics Automation market in the U.S. is estimated at US$1.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 12.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.4% and 7.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.3% CAGR.We bring years of research experience to this 18th edition of our report. The 148-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abaxis Inc.
  • Abbott Diagnostics
  • Beckman Coulter Inc.
  • Becton Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Diagnostica Stago
  • Eppendorf AG
  • HORIBA ABX SAS
  • Hudson Robotics Inc.
  • Ortho Clinical Diagnostics Inc.
  • PerkinElmer Inc.
  • QIAGEN NV
  • Siemens Healthineers
  • Sysmex America Inc.
  • Tecan Group Ltd.
  • Thermo Fischer Scientific Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Global Cell-based Assays Market Witnesses Rapid Growth
    • Recent Market Activity
    • Drug Discovery Leads the Cell-based Assays Application
    • Major Types of Cell-Based HTS Assays for Drug Screening
    • A Glance at Growth Drivers and Market Challenges
    • Developed Regions Lead the Market, Developing Regions to Witness Fastest Growth
    • Increased Spending on Pharma R&D Spurs the Cell-based Assays Market
    • China and India: Hot Spots for R&D Investment
    • Growing Prominence of Cell-based Assays in Drug Discovery
    • Cell-based Assays in HTS and UHTS
    • Resolving Technical Limitations: Cornerstone for Future Success of Cell-based HTS
    • High-Content Screening (HCS) - An Expanding Technology in Cell-Based Assays
    • High Content Screening - Key Application Areas
    • HCS Market Ripe with Growth Opportunity
    • HCS vs. HTS
    • Use of Cell-based Assays in ADME-Toxicity Testing Gains Traction
    • Growing Inclination towards In-vitro Assays for Toxicology Studies
    • Hepatotoxicity Testing Occupies Largest Market Share
    • Cell-Based Assays Emerge as a Popular Tool in Basic Research
    • Global Competitor Market Shares
    • Cell-Based Assays Competitor Market Share Scenario Worldwide (in %): 2018 &
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
    • BD Biosciences (USA)
    • Beckman Coulter, Inc. (USA)
    • BioVision, Inc. (USA)
    • Cisbio Bioassays (USA)
    • Eurofins DiscoverX Corporation (USA)
    • Merck KgaA, (Germany)
    • Enzo Life Sciences, Inc. (USA)
    • Evotec AG (Germany)
    • GE Healthcare Life Sciences (UK)
    • New England Biolabs, Inc. (USA)
    • PerkinElmer, Inc. (USA)
    • Promega Corporation (USA)
    • ProQinase GmbH (Germany)
    • Qiagen NV (The Netherlands)
    • Thermo Fisher Scientific, Inc. (USA)
    • Xenometrix AG (Switzerland)
  • 3. MARKET TRENDS & DRIVERS
    • Pharmaceutical Industry Leads the Way
    • Rising Number of Drug Targets Surge Demand for Cell-Based Assays
    • Rising Investment in Proteomics R&D Drive Cell-based Assays Market
    • Growing Focus on the Development of Reproducible and Robust Cell-based Assays
    • Shift towards High Throughput Research Builds Momentum for HTS
    • Stem Cells Exude Great Potential in Drug Toxicity Testing
    • Global Market for Stem Cell-Assays
    • Functional Assays: An Effective Way of Predicting Specific Toxic Effects
    • Innovation in Screening Guarantees Success for Drug Discovery Programs
    • 3D Cell Culture Technology to Put a New Spin on In Vitro Cell Analyses
    • Automated Multiplexing Platforms Present Growth Opportunities
    • Miniaturized Cell-based Assays on the Horizon
    • Automation of Cell-based Assays: A Growing Trend
    • Technology Advances in Drug Discovery Processes Spurs Cell-Based Assay Market
    • Development of Label-free Cell-based Assays: A Recent Trend in Biological Assays
    • Microfluidics Systems in Cell-based Assays
    • Raman Spectroscopy: An Attractive Analytical Tool for Pharmaceutical Industry
    • Fluorescence Spectroscopy for Cellular Imaging Analyses
    • Cell-based Immunoassays: Novel Assay Technology for Autoantibodies Detection
    • Shift Away from Established Cell Lines to Primary Cells
    • Role of Cell-based Assays in Personalized Medicine: A Research Focus
    • Select Innovations in Cell-based Assays Market
    • CROs - The Targeted Customers for Cell-based Assays
    • Outsourcing of R&D Projects to Propel CRO Market, Driving CTMS Demand
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: Cell-Based Assays Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020
    • TABLE 2: Cell-Based Assays Global Retrospective Market Scenario in US$ Million by Region/Country: 2012
    • TABLE 3: Cell-Based Assays Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS
    • TABLE 4: Consumables (Type) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 5: Consumables (Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to
    • TABLE 6: Consumables (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS
    • TABLE 7: Instruments (Type) Potential Growth Markets Worldwide in US$ Million: 2020 to
    • TABLE 8: Instruments (Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to
    • TABLE 9: Instruments (Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS
    • TABLE 10: Services (Type) Geographic Market Spread Worldwide in US$ Million: 2020 to
    • TABLE 11: Services (Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to
    • TABLE 12: Services (Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 13: Software (Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to
    • TABLE 14: Software (Type) Market Historic Review by Region/Country in US$ Million: 2012 to
    • TABLE 15: Software (Type) Market Share Breakdown by Region/Country: 2012 VS 2020 VS
    • TABLE 16: Drug Discovery (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020
    • TABLE 17: Drug Discovery (Application) Global Historic Analysis in US$ Million by Region/Country: 2012
    • TABLE 18: Drug Discovery (Application) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS
    • TABLE 19: ADME Testing (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through
    • TABLE 20: ADME Testing (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to
    • TABLE 21: ADME Testing (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and
    • TABLE 22: Basic Research (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020
    • TABLE 23: Basic Research (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012
    • TABLE 24: Basic Research (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Cell-Based Assays Market Share (in %) by Company: 2018 &
    • Market Analytics
    • TABLE 25: United States Cell-Based Assays Market Estimates and Projections in US$ Million by Type: 2020 to
    • TABLE 26: Cell-Based Assays Market in the United States by Type: A Historic Review in US$ Million for 2012
    • TABLE 27: United States Cell-Based Assays Market Share Breakdown by Type: 2012 VS 2020 VS
    • TABLE 28: United States Cell-Based Assays Latent Demand Forecasts in US$ Million by Application: 2020 to
    • TABLE 29: Cell-Based Assays Historic Demand Patterns in the United States by Application in US$ Million for 2012
    • TABLE 30: Cell-Based Assays Market Share Breakdown in the United States by Application: 2012 VS 2020 VS
  • CANADA
    • TABLE 31: Canadian Cell-Based Assays Market Estimates and Forecasts in US$ Million by Type: 2020 to
    • TABLE 32: Canadian Cell-Based Assays Historic Market Review by Type in US$ Million: 2012
    • TABLE 33: Cell-Based Assays Market in Canada: Percentage Share Breakdown of Sales by Type for 2012, 2020, and
    • TABLE 34: Canadian Cell-Based Assays Market Quantitative Demand Analysis in US$ Million by Application: 2020 to
    • TABLE 35: Cell-Based Assays Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2012
    • TABLE 36: Canadian Cell-Based Assays Market Share Analysis by Application: 2012 VS 2020 VS
  • JAPAN
    • TABLE 37: Japanese Market for Cell-Based Assays: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2020
    • TABLE 38: Cell-Based Assays Market in Japan: Historic Sales Analysis in US$ Million by Type for the Period 2012
    • TABLE 39: Japanese Cell-Based Assays Market Share Analysis by Type: 2012 VS 2020 VS
    • TABLE 40: Japanese Demand Estimates and Forecasts for Cell-Based Assays in US$ Million by Application: 2020 to
    • TABLE 41: Japanese Cell-Based Assays Market in US$ Million by Application: 2012
    • TABLE 42: Cell-Based Assays Market Share Shift in Japan by Application: 2012 VS 2020 VS
  • CHINA
    • TABLE 43: Chinese Cell-Based Assays Market Growth Prospects in US$ Million by Type for the Period 2020
    • TABLE 44: Cell-Based Assays Historic Market Analysis in China in US$ Million by Type: 2012
    • TABLE 45: Chinese Cell-Based Assays Market by Type: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 46: Chinese Demand for Cell-Based Assays in US$ Million by Application: 2020 to
    • TABLE 47: Cell-Based Assays Market Review in China in US$ Million by Application: 2012
    • TABLE 48: Chinese Cell-Based Assays Market Share Breakdown by Application: 2012 VS 2020 VS
  • EUROPE
    • Market Facts & Figures
    • European Cell-Based Assays Market: Competitor Market Share Scenario (in %) for 2018 &
    • Market Analytics
    • TABLE 49: European Cell-Based Assays Market Demand Scenario in US$ Million by Region/Country: 2020
    • TABLE 50: Cell-Based Assays Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012
    • TABLE 51: European Cell-Based Assays Market Share Shift by Region/Country: 2012 VS 2020 VS
    • TABLE 52: European Cell-Based Assays Market Estimates and Forecasts in US$ Million by Type: 2020
    • TABLE 53: Cell-Based Assays Market in Europe in US$ Million by Type: A Historic Review for the Period 2012
    • TABLE 54: European Cell-Based Assays Market Share Breakdown by Type: 2012 VS 2020 VS
    • TABLE 55: European Cell-Based Assays Addressable Market Opportunity in US$ Million by Application: 2020
    • TABLE 56: Cell-Based Assays Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012
    • TABLE 57: European Cell-Based Assays Market Share Analysis by Application: 2012 VS 2020 VS
  • FRANCE
    • TABLE 58: Cell-Based Assays Market in France by Type: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 59: French Cell-Based Assays Historic Market Scenario in US$ Million by Type: 2012
    • TABLE 60: French Cell-Based Assays Market Share Analysis by Type: 2012 VS 2020 VS
    • TABLE 61: Cell-Based Assays Quantitative Demand Analysis in France in US$ Million by Application: 2020
    • TABLE 62: French Cell-Based Assays Historic Market Review in US$ Million by Application: 2012
    • TABLE 63: French Cell-Based Assays Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and
  • GERMANY
    • TABLE 64: Cell-Based Assays Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020
    • TABLE 65: German Cell-Based Assays Historic Market Analysis in US$ Million by Type: 2012
    • TABLE 66: German Cell-Based Assays Market Share Breakdown by Type: 2012 VS 2020 VS
    • TABLE 67: Cell-Based Assays Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020
    • TABLE 68: German Cell-Based Assays Market in Retrospect in US$ Million by Application: 2012
    • TABLE 69: Cell-Based Assays Market Share Distribution in Germany by Application: 2012 VS 2020 VS
  • ITALY
    • TABLE 70: Italian Cell-Based Assays Market Growth Prospects in US$ Million by Type for the Period 2020
    • TABLE 71: Cell-Based Assays Historic Market Analysis in Italy in US$ Million by Type: 2012
    • TABLE 72: Italian Cell-Based Assays Market by Type: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 73: Italian Demand for Cell-Based Assays in US$ Million by Application: 2020 to
    • TABLE 74: Cell-Based Assays Market Review in Italy in US$ Million by Application: 2012
    • TABLE 75: Italian Cell-Based Assays Market Share Breakdown by Application: 2012 VS 2020 VS
  • UNITED KINGDOM
    • TABLE 76: United Kingdom Market for Cell-Based Assays: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2020
    • TABLE 77: Cell-Based Assays Market in the United Kingdom: Historic Sales Analysis in US$ Million by Type for the Period 2012
    • TABLE 78: United Kingdom Cell-Based Assays Market Share Analysis by Type: 2012 VS 2020 VS
    • TABLE 79: United Kingdom Demand Estimates and Forecasts for Cell-Based Assays in US$ Million by Application: 2020 to
    • TABLE 80: United Kingdom Cell-Based Assays Market in US$ Million by Application: 2012
    • TABLE 81: Cell-Based Assays Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS
  • SPAIN
    • TABLE 82: Spanish Cell-Based Assays Market Estimates and Forecasts in US$ Million by Type: 2020 to
    • TABLE 83: Spanish Cell-Based Assays Historic Market Review by Type in US$ Million: 2012
    • TABLE 84: Cell-Based Assays Market in Spain: Percentage Share Breakdown of Sales by Type for 2012, 2020, and
    • TABLE 85: Spanish Cell-Based Assays Market Quantitative Demand Analysis in US$ Million by Application: 2020 to
    • TABLE 86: Cell-Based Assays Market in Spain: Summarization of Historic Demand Patterns in US$ Million by Application for 2012
    • TABLE 87: Spanish Cell-Based Assays Market Share Analysis by Application: 2012 VS 2020 VS
  • RUSSIA
    • TABLE 88: Russian Cell-Based Assays Market Estimates and Projections in US$ Million by Type: 2020 to
    • TABLE 89: Cell-Based Assays Market in Russia by Type: A Historic Review in US$ Million for 2012
    • TABLE 90: Russian Cell-Based Assays Market Share Breakdown by Type: 2012 VS 2020 VS
    • TABLE 91: Russian Cell-Based Assays Latent Demand Forecasts in US$ Million by Application: 2020 to
    • TABLE 92: Cell-Based Assays Historic Demand Patterns in Russia by Application in US$ Million for 2012
    • TABLE 93: Cell-Based Assays Market Share Breakdown in Russia by Application: 2012 VS 2020 VS
  • REST OF EUROPE
    • TABLE 94: Rest of Europe Cell-Based Assays Market Estimates and Forecasts in US$ Million by Type: 2020
    • TABLE 95: Cell-Based Assays Market in Rest of Europe in US$ Million by Type: A Historic Review for the Period 2012
    • TABLE 96: Rest of Europe Cell-Based Assays Market Share Breakdown by Type: 2012 VS 2020 VS
    • TABLE 97: Rest of Europe Cell-Based Assays Addressable Market Opportunity in US$ Million by Application: 2020
    • TABLE 98: Cell-Based Assays Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012
    • TABLE 99: Rest of Europe Cell-Based Assays Market Share Analysis by Application: 2012 VS 2020 VS
  • ASIA-PACIFIC
    • TABLE 100: Asia-Pacific Cell-Based Assays Market Estimates and Forecasts in US$ Million by Region/Country: 2020
    • TABLE 101: Cell-Based Assays Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012
    • TABLE 102: Asia-Pacific Cell-Based Assays Market Share Analysis by Region/Country: 2012 VS 2020 VS
    • TABLE 103: Cell-Based Assays Market in Asia-Pacific by Type: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 104: Asia-Pacific Cell-Based Assays Historic Market Scenario in US$ Million by Type: 2012
    • TABLE 105: Asia-Pacific Cell-Based Assays Market Share Analysis by Type: 2012 VS 2020 VS
    • TABLE 106: Cell-Based Assays Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020
    • TABLE 107: Asia-Pacific Cell-Based Assays Historic Market Review in US$ Million by Application: 2012
    • TABLE 108: Asia-Pacific Cell-Based Assays Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and
  • AUSTRALIA
    • TABLE 109: Cell-Based Assays Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020
    • TABLE 110: Australian Cell-Based Assays Historic Market Analysis in US$ Million by Type: 2012
    • TABLE 111: Australian Cell-Based Assays Market Share Breakdown by Type: 2012 VS 2020 VS
    • TABLE 112: Cell-Based Assays Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020
    • TABLE 113: Australian Cell-Based Assays Market in Retrospect in US$ Million by Application: 2012
    • TABLE 114: Cell-Based Assays Market Share Distribution in Australia by Application: 2012 VS 2020 VS
  • INDIA
    • TABLE 115: Indian Cell-Based Assays Market Estimates and Forecasts in US$ Million by Type: 2020 to
    • TABLE 116: Indian Cell-Based Assays Historic Market Review by Type in US$ Million: 2012
    • TABLE 117: Cell-Based Assays Market in India: Percentage Share Breakdown of Sales by Type for 2012, 2020, and
    • TABLE 118: Indian Cell-Based Assays Market Quantitative Demand Analysis in US$ Million by Application: 2020 to
    • TABLE 119: Cell-Based Assays Market in India: Summarization of Historic Demand Patterns in US$ Million by Application for 2012
    • TABLE 120: Indian Cell-Based Assays Market Share Analysis by Application: 2012 VS 2020 VS
  • SOUTH KOREA
    • TABLE 121: Cell-Based Assays Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020
    • TABLE 122: South Korean Cell-Based Assays Historic Market Analysis in US$ Million by Type: 2012
    • TABLE 123: Cell-Based Assays Market Share Distribution in South Korea by Type: 2012 VS 2020 VS
    • TABLE 124: Cell-Based Assays Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2020
    • TABLE 125: South Korean Cell-Based Assays Historic Market Analysis in US$ Million by Application: 2012
    • TABLE 126: Cell-Based Assays Market Share Distribution in South Korea by Application: 2012 VS 2020 VS
  • REST OF ASIA-PACIFIC
    • TABLE 127: Rest of Asia-Pacific Market for Cell-Based Assays: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2020
    • TABLE 128: Cell-Based Assays Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Type for the Period 2012
    • TABLE 129: Rest of Asia-Pacific Cell-Based Assays Market Share Analysis by Type: 2012 VS 2020 VS
    • TABLE 130: Rest of Asia-Pacific Demand Estimates and Forecasts for Cell-Based Assays in US$ Million by Application: 2020 to
    • TABLE 131: Rest of Asia-Pacific Cell-Based Assays Market in US$ Million by Application: 2012
    • TABLE 132: Cell-Based Assays Market Share Shift in Rest of Asia-Pacific by Application: 2012 VS 2020 VS
  • LATIN AMERICA
    • TABLE 133: Latin American Cell-Based Assays Market Trends by Region/Country in US$ Million: 2020
    • TABLE 134: Cell-Based Assays Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012
    • TABLE 135: Latin American Cell-Based Assays Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and
    • TABLE 136: Latin American Cell-Based Assays Market Growth Prospects in US$ Million by Type for the Period 2020
    • TABLE 137: Cell-Based Assays Historic Market Analysis in Latin America in US$ Million by Type: 2012
    • TABLE 138: Latin American Cell-Based Assays Market by Type: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 139: Latin American Demand for Cell-Based Assays in US$ Million by Application: 2020 to
    • TABLE 140: Cell-Based Assays Market Review in Latin America in US$ Million by Application: 2012
    • TABLE 141: Latin American Cell-Based Assays Market Share Breakdown by Application: 2012 VS 2020 VS
  • ARGENTINA
    • TABLE 142: Argentinean Cell-Based Assays Market Estimates and Forecasts in US$ Million by Type: 2020
    • TABLE 143: Cell-Based Assays Market in Argentina in US$ Million by Type: A Historic Review for the Period 2012
    • TABLE 144: Argentinean Cell-Based Assays Market Share Breakdown by Type: 2012 VS 2020 VS
    • TABLE 145: Argentinean Cell-Based Assays Addressable Market Opportunity in US$ Million by Application: 2020
    • TABLE 146: Cell-Based Assays Market in Argentina: Summarization of Historic Demand in US$ Million by Application for the Period 2012
    • TABLE 147: Argentinean Cell-Based Assays Market Share Analysis by Application: 2012 VS 2020 VS
  • BRAZIL
    • TABLE 148: Cell-Based Assays Market in Brazil by Type: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 149: Brazilian Cell-Based Assays Historic Market Scenario in US$ Million by Type: 2012
    • TABLE 150: Brazilian Cell-Based Assays Market Share Analysis by Type: 2012 VS 2020 VS
    • TABLE 151: Cell-Based Assays Quantitative Demand Analysis in Brazil in US$ Million by Application: 2020
    • TABLE 152: Brazilian Cell-Based Assays Historic Market Review in US$ Million by Application: 2012
    • TABLE 153: Brazilian Cell-Based Assays Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and
  • MEXICO
    • TABLE 154: Cell-Based Assays Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020
    • TABLE 155: Mexican Cell-Based Assays Historic Market Analysis in US$ Million by Type: 2012
    • TABLE 156: Mexican Cell-Based Assays Market Share Breakdown by Type: 2012 VS 2020 VS
    • TABLE 157: Cell-Based Assays Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020
    • TABLE 158: Mexican Cell-Based Assays Market in Retrospect in US$ Million by Application: 2012
    • TABLE 159: Cell-Based Assays Market Share Distribution in Mexico by Application: 2012 VS 2020 VS
  • REST OF LATIN AMERICA
    • TABLE 160: Rest of Latin America Cell-Based Assays Market Estimates and Projections in US$ Million by Type: 2020 to
    • TABLE 161: Cell-Based Assays Market in Rest of Latin America by Type: A Historic Review in US$ Million for 2012
    • TABLE 162: Rest of Latin America Cell-Based Assays Market Share Breakdown by Type: 2012 VS 2020 VS
    • TABLE 163: Rest of Latin America Cell-Based Assays Latent Demand Forecasts in US$ Million by Application: 2020 to
    • TABLE 164: Cell-Based Assays Historic Demand Patterns in Rest of Latin America by Application in US$ Million for 2012
    • TABLE 165: Cell-Based Assays Market Share Breakdown in Rest of Latin America by Application: 2012 VS 2020 VS
  • MIDDLE EAST
    • TABLE 166: The Middle East Cell-Based Assays Market Estimates and Forecasts in US$ Million by Region/Country: 2020
    • TABLE 167: Cell-Based Assays Market in the Middle East by Region/Country in US$ Million: 2012
    • TABLE 168: The Middle East Cell-Based Assays Market Share Breakdown by Region/Country: 2012, 2020, and
    • TABLE 169: The Middle East Cell-Based Assays Market Estimates and Forecasts in US$ Million by Type: 2020 to
    • TABLE 170: The Middle East Cell-Based Assays Historic Market by Type in US$ Million: 2012
    • TABLE 171: Cell-Based Assays Market in the Middle East: Percentage Share Breakdown of Sales by Type for 2012,2020, and
    • TABLE 172: The Middle East Cell-Based Assays Market Quantitative Demand Analysis in US$ Million by Application: 2020 to
    • TABLE 173: Cell-Based Assays Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by Application for 2012
    • TABLE 174: The Middle East Cell-Based Assays Market Share Analysis by Application: 2012 VS 2020 VS
  • IRAN
    • TABLE 175: Iranian Market for Cell-Based Assays: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2020
    • TABLE 176: Cell-Based Assays Market in Iran: Historic Sales Analysis in US$ Million by Type for the Period 2012
    • TABLE 177: Iranian Cell-Based Assays Market Share Analysis by Type: 2012 VS 2020 VS
    • TABLE 178: Iranian Demand Estimates and Forecasts for Cell-Based Assays in US$ Million by Application: 2020 to
    • TABLE 179: Iranian Cell-Based Assays Market in US$ Million by Application: 2012
    • TABLE 180: Cell-Based Assays Market Share Shift in Iran by Application: 2012 VS 2020 VS
  • ISRAEL
    • TABLE 181: Israeli Cell-Based Assays Market Estimates and Forecasts in US$ Million by Type: 2020
    • TABLE 182: Cell-Based Assays Market in Israel in US$ Million by Type: A Historic Review for the Period 2012
    • TABLE 183: Israeli Cell-Based Assays Market Share Breakdown by Type: 2012 VS 2020 VS
    • TABLE 184: Israeli Cell-Based Assays Addressable Market Opportunity in US$ Million by Application: 2020
    • TABLE 185: Cell-Based Assays Market in Israel: Summarization of Historic Demand in US$ Million by Application for the Period 2012
    • TABLE 186: Israeli Cell-Based Assays Market Share Analysis by Application: 2012 VS 2020 VS
  • SAUDI ARABIA
    • TABLE 187: Saudi Arabian Cell-Based Assays Market Growth Prospects in US$ Million by Type for the Period 2020
    • TABLE 188: Cell-Based Assays Historic Market Analysis in Saudi Arabia in US$ Million by Type: 2012
    • TABLE 189: Saudi Arabian Cell-Based Assays Market by Type: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 190: Saudi Arabian Demand for Cell-Based Assays in US$ Million by Application: 2020 to
    • TABLE 191: Cell-Based Assays Market Review in Saudi Arabia in US$ Million by Application: 2012
    • TABLE 192: Saudi Arabian Cell-Based Assays Market Share Breakdown by Application: 2012 VS 2020 VS
  • UNITED ARAB EMIRATES
    • TABLE 193: Cell-Based Assays Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020
    • TABLE 194: United Arab Emirates Cell-Based Assays Historic Market Analysis in US$ Million by Type: 2012
    • TABLE 195: Cell-Based Assays Market Share Distribution in United Arab Emirates by Type: 2012 VS 2020 VS
    • TABLE 196: Cell-Based Assays Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2020
    • TABLE 197: United Arab Emirates Cell-Based Assays Historic Market Analysis in US$ Million by Application: 2012
    • TABLE 198: Cell-Based Assays Market Share Distribution in United Arab Emirates by Application: 2012 VS 2020 VS
  • REST OF MIDDLE EAST
    • TABLE 199: Cell-Based Assays Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020
    • TABLE 200: Rest of Middle East Cell-Based Assays Historic Market Analysis in US$ Million by Type: 2012
    • TABLE 201: Rest of Middle East Cell-Based Assays Market Share Breakdown by Type: 2012 VS 2020 VS
    • TABLE 202: Cell-Based Assays Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020
    • TABLE 203: Rest of Middle East Cell-Based Assays Market in Retrospect in US$ Million by Application: 2012
    • TABLE 204: Cell-Based Assays Market Share Distribution in Rest of Middle East by Application: 2012 VS 2020 VS
  • AFRICA
    • TABLE 205: African Cell-Based Assays Market Estimates and Projections in US$ Million by Type: 2020 to
    • TABLE 206: Cell-Based Assays Market in Africa by Type: A Historic Review in US$ Million for 2012
    • TABLE 207: African Cell-Based Assays Market Share Breakdown by Type: 2012 VS 2020 VS
    • TABLE 208: African Cell-Based Assays Latent Demand Forecasts in US$ Million by Application: 2020 to
    • TABLE 209: Cell-Based Assays Historic Demand Patterns in Africa by Application in US$ Million for 2012
    • TABLE 210: Cell-Based Assays Market Share Breakdown in Africa by Application: 2012 VS 2020 VS

IV. COMPETITION

  • Total Companies Profiled: 57